Browse every story filed under this topic, curated from trusted publishers around the world.
Pfizer’s victory in delaying Vyndamax generics is mixed bag for BridgeBio: analysts
Pfizer now anticipates its Vyndamax sales to remain “relatively stable” from 2028 through mid-2031, it said.
Read full story →
STAT+: Supreme Court to hear case about ‘skinny labeling’ and generic access
The Supreme Court on Wednesday will hear oral arguments about a simmering controversy over so-called skinny labels, with implications for …
Pfizer settles with 2 generic Vyndamax makers in latest twist to ATTR market: analysts
Eleventh-hour settlements with two of the three generic drugmakers involved could bode well for both Pfizer and its ATTR competitor …
Sun Pharma strikes biopharma's largest deal of '26 with $11.75B buyout of Organon
Already the largest biopharma company in India, generics powerhouse Sun Pharma has doubled in size with its acquisition of women’s …
Democrats hold 6-point advantage in battleground districts: Poll
Voters in key battleground districts say they would back the average Democrat over the generic Republican as their representative in …
What 10,000 Hires Taught Me About How AI Ranks Everything
If your inputs are generic, your results will be too whether you’re hiring talent or showing up in AI search.
Five ways hotel marketers are turning summer traffic into direct bookings
Hotels are using AI-driven personalization and behavioral targeting to convert summer website traffic into direct bookings rather than relying on …
You've seen all articles for #generics.
Check back
soon
for new stories.